158 related articles for article (PubMed ID: 9016899)
1. Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats.
Cowley BD; Rupp JC; Muessel MJ; Gattone VH
Am J Kidney Dis; 1997 Feb; 29(2):265-72. PubMed ID: 9016899
[TBL] [Abstract][Full Text] [Related]
2. Modification of disease progression in rats with inherited polycystic kidney disease.
Cowley BD; Grantham JJ; Muessel MJ; Kraybill AL; Gattone VH
Am J Kidney Dis; 1996 Jun; 27(6):865-79. PubMed ID: 8651252
[TBL] [Abstract][Full Text] [Related]
3. Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats.
Cowley BD; Ricardo SD; Nagao S; Diamond JR
Kidney Int; 2001 Dec; 60(6):2087-96. PubMed ID: 11737583
[TBL] [Abstract][Full Text] [Related]
4. Renal concentration of alpha-tocopherol: dependence on gender and lack of effect on polycystic kidney disease in Han:SPRD rats.
Torres VE; Bengal RJ; Nickander KK; Grande JP; Low PA
Am J Kidney Dis; 1998 Apr; 31(4):687-93. PubMed ID: 9531187
[TBL] [Abstract][Full Text] [Related]
5. The effect of paclitaxel on the progression of polycystic kidney disease in rodents.
Martinez JR; Cowley BD; Gattone VH; Nagao S; Yamaguchi T; Kaneta S; Takahashi H; Grantham JJ
Am J Kidney Dis; 1997 Mar; 29(3):435-44. PubMed ID: 9041221
[TBL] [Abstract][Full Text] [Related]
6. Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease.
Gattone VH; Siqueira TM; Powell CR; Trambaugh CM; Lingeman JE; Shalhav AL
Exp Biol Med (Maywood); 2008 Aug; 233(8):952-7. PubMed ID: 18480417
[TBL] [Abstract][Full Text] [Related]
7. Gender hormones and the progression of experimental polycystic kidney disease.
Stringer KD; Komers R; Osman SA; Oyama TT; Lindsley JN; Anderson S
Kidney Int; 2005 Oct; 68(4):1729-39. PubMed ID: 16164649
[TBL] [Abstract][Full Text] [Related]
8. Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease.
Tao Y; Kim J; Faubel S; Wu JC; Falk SA; Schrier RW; Edelstein CL
Proc Natl Acad Sci U S A; 2005 May; 102(19):6954-9. PubMed ID: 15863619
[TBL] [Abstract][Full Text] [Related]
9. Autosomal-dominant polycystic kidney disease in the rat.
Cowley BD; Gudapaty S; Kraybill AL; Barash BD; Harding MA; Calvet JP; Gattone VH
Kidney Int; 1993 Mar; 43(3):522-34. PubMed ID: 8455352
[TBL] [Abstract][Full Text] [Related]
10. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease.
Turner CM; Ramesh B; Srai SK; Burnstock G; Unwin RJ
Cells Tissues Organs; 2004; 178(3):168-79. PubMed ID: 15655334
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor pathway in rats with autosomal dominant polycystic kidney disease.
Nagao S; Kusaka M; Nishii K; Marunouchi T; Kurahashi H; Takahashi H; Grantham J
J Am Soc Nephrol; 2005 Jul; 16(7):2052-62. PubMed ID: 15888569
[TBL] [Abstract][Full Text] [Related]
12. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
Banković-Calić N; Ogbori MR; Nicman E
Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
[TBL] [Abstract][Full Text] [Related]
14. Azotemia and extrarenal manifestations in old female Han:SPRD (cy/+) rats.
Kränzlin B; Schieren G; Gretz N
Kidney Int; 1997 Apr; 51(4):1160-9. PubMed ID: 9083282
[TBL] [Abstract][Full Text] [Related]
15. Progression of renal failure in the Han: SPRD polycystic kidney rat.
Zeier M; Pohlmeyer G; Deerberg F; Schönherr R; Ritz E
Nephrol Dial Transplant; 1994; 9(12):1734-9. PubMed ID: 7708256
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of [¹⁸F]PFH PET renography to predict future disease progression in a rat model of autosomal dominant polycystic kidney disease.
Pathuri G; Hedrick AF; Awasthi V; Cowley BD; Gali H
Nucl Med Biol; 2016 Jan; 43(1):1-5. PubMed ID: 26702780
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease.
Tao Y; Kim J; Schrier RW; Edelstein CL
J Am Soc Nephrol; 2005 Jan; 16(1):46-51. PubMed ID: 15563559
[TBL] [Abstract][Full Text] [Related]
18. A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease.
Pey R; Bach J; Schieren G; Gretz N; Hafner M
In Vitro Cell Dev Biol Anim; 1999; 35(10):571-9. PubMed ID: 10614866
[TBL] [Abstract][Full Text] [Related]
19. Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat.
Gile RD; Cowley BD; Gattone VH; O'Donnell MP; Swan SK; Grantham JJ
Am J Kidney Dis; 1995 Sep; 26(3):501-7. PubMed ID: 7645559
[TBL] [Abstract][Full Text] [Related]
20. CTGF Is Expressed During Cystic Remodeling in the PKD/Mhm (cy/+) Rat Model for Autosomal-Dominant Polycystic Kidney Disease (ADPKD).
Gauer S; Holzmann Y; Kränzlin B; Hoffmann SC; Gretz N; Hauser IA; Goppelt-Struebe M; Geiger H; Obermüller N
J Histochem Cytochem; 2017 Dec; 65(12):743-755. PubMed ID: 29058957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]